New customs programme grants trusted drug companies faster clearance and simplified procedures
Emirates Drug Establishment
Latest in Emirates Drug Establishment
Emirates Drug Establishment
UAE issues recall of additional Nestlé infant formula
Authorities confirm that three more batches of Nestlé products are being withdrawn as a precaution to protect infant health and consumer safety
Emirates Drug Establishment
UAE becomes second country to approve heart failure drug Inpefa
Helps individuals living with heart failure, or those at risk of developing it, by reducing complications and lowering the risk of serious cardiovascular problems
Emirates Drug Establishment
UAE recalls Nestlé infant formula products
The Emirates Drug Establishment recalls selected Nestlé infant formula products over concerns over traces of bacteria
Emirates Drug Establishment
MoHAP transfers several pharma-related services to Emirates Drug Establishment
The strategic move aims to unify mandates, clarify institutional roles, and strengthen integration among relevant government entities
Emirates Drug Establishment
UAE expands access to gene therapy for spinal muscular atrophy patients
Regulator approves Itvisma for adults and children aged two and above, positioning the UAE among the first countries globally to authorise the treatment for a wider age group
Emirates Drug Establishment
UAE launches nationwide crackdown on medicine safety
New inspection blitz trains pharma firms to catch risks early and protect patients across the country
